OUR SPONSOR

Redbow Consulting Group

Founded in 2013 by Jonathan Dancer, Redbow Consulting Group is a pharmaceutical strategy consultancy founded in 2013 by Jonathan Dancer. Its mission is to create and enhance value in healthcare and its primary focus is on strategy development for pharma and healthcare clients. Redbow has built a range of proprietary innovative tools and processes including web-based and agentic AI applications. Over the past decade the firm pioneered, perfected and recently commercialised an innovative strategy model, Directional SWOT® , which dramatically improves the depth, quality and outcomes of the strategic narrative teams are able to create. Redbow’s current focus is primarily on Europe in the area of strategy development and the development of human centred workflows in the context of agentic AI.

InstaPill®

InstaPill® is a globally recognized pharmaceutical CDMO specializing in innovative orally disintegrating tablet (ODT) technologies and advanced drug delivery solutions. Headquartered in Bengaluru, India, the company focuses on developing fast-dissolving, patient-friendly pharmaceutical formulations designed to improve medication adherence and patient experience. Through its proprietary InstaPill® technology platform, the company enables pharmaceutical and healthcare organizations to create convenient dosage forms that dissolve rapidly without the need for water, making them particularly beneficial for pediatric, geriatric, and dysphagic patients. InstaPill® provides end-to-end support across the pharmaceutical value chain, including formulation development, clinical manufacturing, scale-up, regulatory support, and commercial production. The company operates through highly automated, internationally compliant manufacturing facilities and holds approvals from major global regulatory authorities including the USFDA, EU, MHRA, Health Canada, and TGA. With a strong focus on innovation, quality, and patient-centric healthcare solutions, InstaPill® continues to support pharmaceutical companies worldwide in accelerating product development and improving accessibility to advanced oral drug delivery systems.

AtheroCare

AtheroCare is a healthcare innovation company focused on advancing cardiovascular care through preventive healthcare solutions, diagnostics, patient education, and technology-driven medical services. The company is dedicated to addressing the growing global burden of cardiovascular diseases by promoting early detection, personalized risk assessment, and proactive disease management strategies. By combining clinical expertise with modern healthcare technologies, AtheroCare aims to improve patient outcomes while supporting healthcare providers with efficient and evidence-based care solutions. AtheroCare collaborates with healthcare professionals, hospitals, medical institutions, and industry partners to develop patient-centric approaches that emphasize prevention, awareness, and long-term cardiovascular wellness. Their work spans across healthcare innovation, clinical support, and initiatives designed to improve accessibility to quality cardiovascular care. With a strong focus on precision medicine and digital healthcare integration, AtheroCare continues to contribute to the evolving healthcare ecosystem by supporting smarter, more connected, and more preventive models of patient care.

WAVESTONE